statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences PR Newswire...

Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences

This indicator may be signaling DNLI's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Denali Therapeutics (DNLI, $20.5) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

It has been about a month since the last earnings report for Sarepta Therapeutics (SRPT). Shares have added about 1.2% in that time frame, underperforming the S&P 500.Will the recent positive trend...

Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares have added about 2.8% in that time frame, underperforming the S&P 500.Will the recent positive trend...

Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?

Denali Therapeutics files to sell 29.29M shares of common stock for holders...

Denali Therapeutics files to sell 29.29M shares of common stock for holders

Denali Therapeutics (DNLI, $20.54) entered Uptrend as Momentum indicator ascends above 0 level on Mar 19, 2024

Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative...

Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024

This is a Bearish indicator signaling DNLI's price could decline from here. Traders may explore shorting the stock or put options...

Denali Therapeutics (DNLI, $20.13) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 15, 2024

Denali Therapeutics (DNLI, $20.9) entered Uptrend as Momentum indicator ascends above 0 level on Mar 13, 2024

Northern Trust Corp grew its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI  Free Report) by 2.5% during the third quarter, according to the company in its most recent 13F filing...

Northern Trust Corp Boosts Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

Volume	868,040.00
52-Wk High	$33.31
52-Wk Low	$14.56

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.69	--	--	N/A
Q4'23	-$0.81	-$0.86	-6.50%	MISSED
Q3'23	-$0.81	-$0.72	11.09%	BEAT
Q2'23	-$0.69	$1.30	287.24%	BEAT
Q1'23	-$0.70	-$0.80	-14.17%	MISSED

DNLI Denali Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals